Cinnamon / HO-1 Cancer Research Results

Cin, Cinnamon: Click to Expand ⟱

Features:

Cinnamon is a spice from inner bark from several tree species.
Cinnamon refers primarily to bark extracts from Cinnamomum verum (Ceylon cinnamon) and Cinnamomum cassia. Bioactive constituents include cinnamaldehyde, cinnamic acid derivatives, procyanidins, and polyphenols. In cancer models, cinnamon extracts and cinnamaldehyde are most frequently reported to exert anti-proliferative, pro-apoptotic, anti-inflammatory, and anti-angiogenic effects. Mechanistic themes include suppression of NF-κB and PI3K/AKT signaling, modulation of MAPK pathways, induction of mitochondrial apoptosis, and context-dependent ROS elevation in tumor cells. Some studies report inhibition of HIF-1α and glycolytic signaling, though cinnamon is not a direct enzymatic Warburg inhibitor. Effects vary substantially depending on species (Ceylon vs Cassia), preparation (aqueous vs ethanol extract), and dose. Human oncology data remain limited and largely preclinical.

-Cinnamaldehyde (CA), an active compound derived from the natural plant cinnamon. CA is an aromatic aldehyde compound, constituting approximately 65% of cinnamon extract
- See also HCA, a derivative of CA

Biological activity, cinnamaldehyde from Ceylon cinnamon:
Antimicrobial activity: 10-50 μM
Antioxidant activity: 10-100 μM
Anti-inflammatory activity: 20-50 μM
Anticancer activity: 50-100 μM
Cardiovascular health: 20-50 μM

5 g of Ceylon cinnamon might contain roughly between 30 mg and 150 mg of cinnamaldehyde, with an approximate mid-range estimate of about 70 mg.
Assuming a moderate supplemental intake 50–200 mg of cinnamaldehyde, peak plasma levels might be anticipated in the vicinity of 1–10 μM.

Primary mechanisms (ranked):

Suppression of inflammatory and survival signaling, especially NF-κB, AP-1, COX-2, PI3K/AKT, and related anti-apoptotic programs.
Induction of mitochondrial apoptosis and cell-cycle arrest in cancer models.
Anti-metastatic and anti-invasive effects linked to glycolysis/HK2 suppression, migration inhibition, and EMT-related signaling changes.
Anti-angiogenic activity through VEGF/VEGFR2/HIF-1α and downstream MAPK signaling modulation.
Redox modulation, with antioxidant/NRF2 activation in normal-cell stress contexts but ROS elevation and apoptosis in some tumor models.

Bioavailability / PK relevance: Cinnamon is compositionally variable; cinnamaldehyde is lipophilic, rapidly absorbed and metabolized, and systemic exposure after oral intake is likely much lower than many in-vitro anticancer concentrations. Extract formulation, species, dose, food matrix, and first-pass metabolism materially affect exposure.

In-vitro vs systemic exposure relevance: Many anticancer studies use extract concentrations or cinnamaldehyde levels that may exceed achievable free systemic exposure after ordinary oral intake. Local gastrointestinal exposure may be more plausible than systemic tumor exposure.

Clinical evidence status: Preclinical for oncology. Cinnamon has human RCT/meta-analysis literature mainly in metabolic/inflammatory endpoints, but no established clinical anticancer indication. Translational constraints include variable extract chemistry, cassia coumarin hepatotoxicity risk, CYP/herb-drug interaction potential, and uncertain tumor-achievable exposure.

Cinnamon Cancer Mechanism Table

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	NF-κB AP-1 inflammatory survival signaling	NF-κB ↓; AP-1 ↓; COX-2 ↓; Bcl-2 family survival tone ↓	Inflammatory tone ↓	R, G	Anti-inflammatory and anti-survival signaling	Core mechanism for cinnamon extract and cinnamaldehyde; model-dependent but repeatedly reported.
2	PI3K AKT mTOR growth signaling	PI3K/AKT ↓; proliferation ↓; apoptosis ↑	↔ or stress protection ↑	R, G	Growth-signal suppression	Most relevant for cinnamaldehyde-rich preparations; linked to colorectal and other cancer models.
3	Mitochondrial apoptosis	Bax ↑; Bcl-2 ↓; mitochondrial dysfunction ↑; caspase activation ↑	↔ at lower exposure; cytotoxicity risk at high exposure	G	Apoptotic induction	Central anticancer mechanism but often requires concentrations above dietary exposure.
4	Glycolysis and HK2 driven invasion	HK2 ↓; G6P/F6P production ↓; migration ↓; invasion ↓	↔	G	Anti-metastatic metabolic suppression	Mechanistically important for metastatic dissemination models; not a broad direct Warburg enzyme inhibitor claim.
5	VEGF VEGFR2 HIF-1α angiogenesis axis	VEGF ↓; HIF-1α ↓; angiogenesis ↓	Endothelial VEGFR2/MAPK signaling ↓ under angiogenic stimulation	R, G	Anti-angiogenic effect	Supported by endothelial, tumor-cell, zebrafish, and mouse xenograft-style evidence.
6	ROS redox stress	ROS ↑ and apoptosis ↑ in some tumor models (dose-dependent)	ROS ↓ or antioxidant response ↑ at lower exposure	P, R	Context-dependent redox modulation	Not simply antioxidant or pro-oxidant; direction depends on compound, dose, exposure time, and cell stress state.
7	NRF2 antioxidant response	NRF2 ↑ may be protective or resistance-relevant (context-dependent)	NRF2 ↑; cytoprotective gene expression ↑	R, G	Stress-response activation	Important safety/normal-cell protection axis; in cancer it may be double-edged if persistent NRF2 supports survival.
8	Cell-cycle regulation	G1 or G2/M arrest ↑; cyclin/CDK signaling ↓	↔	G	Cytostasis	Secondary to upstream growth and stress signaling changes.
9	MAPK stress signaling	JNK/p38 modulation ↑; ERK modulation mixed	↔ or inflammatory MAPK ↓	P, R	Signal reprogramming	Direction varies by model and stimulus; best treated as contextual rather than primary.
10	Clinical Translation Constraint	Systemic exposure uncertain; in-vitro dose gap likely	Cassia coumarin hepatotoxicity risk; CYP interaction potential	G	Translation limitation	Ceylon cinnamon is preferred for repeated higher intake because cassia generally has higher coumarin content.

TSF: P = 0–30 min (redox and early signaling effects), R = 30 min–3 hr (acute pathway modulation), G = >3 hr (apoptosis, angiogenesis, phenotype changes).

HO-1, HMOX1: Click to Expand ⟱

Source:

Type:

(Also known as Hsp32 and HMOX1)
HO-1 is the common abbreviation for the protein (heme oxygenase‑1) produced by the HMOX1 gene.
HO-1 is an enzyme that plays a crucial role in various cellular processes, including the breakdown of heme, a toxic molecule. Research has shown that HO-1 is involved in the development and progression of cancer.
-widely regarded as having antioxidant and cytoprotective effects
-The overall activity of HO‑1 helps to reduce the pro‐oxidant load (by degrading free heme, a pro‑oxidant) and to generate molecules (like bilirubin) that can protect cells from oxidative damage

Studies have found that HO-1 is overexpressed in various types of cancer, including lung, breast, colon, and prostate cancer. The overexpression of HO-1 in cancer cells can contribute to their survival and proliferation by:
Reducing oxidative stress and inflammation
Promoting angiogenesis (the formation of new blood vessels)
Inhibiting apoptosis (programmed cell death)
Enhancing cell migration and invasion
When HO-1 is at a normal level, it mainly exerts an antioxidant effect, and when it is excessively elevated, it causes an accumulation of iron ions.

A proper cellular level of HMOX1 plays an antioxidative function to protect cells from ROS toxicity. However, its overexpression has pro-oxidant effects to induce ferroptosis of cells, which is dependent on intracellular iron accumulation and increased ROS content upon excessive activation of HMOX1.

-Curcumin Activates the Nrf2 pathway leading to HO‑1 induction; known for its anti‑inflammatory and antioxidant effects.
-Resveratrol Induces HO‑1 via activation of SIRT1/Nrf2 signaling; exhibits antioxidant and cardioprotective properties.
-Quercetin Activates Nrf2 and related antioxidant pathways; contributes to anti‑oxidative and anti‑inflammatory responses.
-EGCG Promotes HO‑1 expression through activation of the Nrf2/ARE pathway; also exhibits anti‑inflammatory and anticancer properties.
-Sulforaphane One of the most potent natural HO‑1 inducers; triggers Nrf2 nuclear translocation and upregulates a battery of phase II detoxifying enzymes.
-Luteolin Induces HO‑1 via Nrf2 activation; may also exert anti‑inflammatory and neuroprotective effects in various cell models.
-Apigenin Has been reported to induce HO‑1 expression partly via the MAPK and Nrf2 pathways; also known for anti‑inflammatory and anticancer activities.

Scientific Papers found: Click to Expand⟱

6144-

Cin,

The Cinnamon-Derived Dietary Factor Cinnamic Aldehyde Activates the Nrf2-Dependent Antioxidant Response in Human Epithelial Colon Cells

in-vitro,

Colon,

HCT116

Nrf1↑, HO-1↑, chemoPv↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

HO-1↑, 1, Nrf1↑, 1,

Functional Outcomes ⓘ

chemoPv↑, 1,
Total Targets: 3

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: HO-1, HMOX1

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells